Photo from wikipedia
Split-course stereotactic ablative radiotherapy (SABR) appeared to achieve favorable toxicity profiles and local control outcomes comparable with those of continuous SABR in the patients with oligometastases. Click to show full abstract
Split-course stereotactic ablative radiotherapy (SABR) appeared to achieve favorable toxicity profiles and local control outcomes comparable with those of continuous SABR in the patients with oligometastases.
Keywords:
ablative radiotherapy;
stereotactic ablative;
course stereotactic;
split course
Journal Title: Japanese Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Japanese Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!